Usage of MicroRNA in Potential Therapeutics of Ewing?s Sarcoma
Received Date: Jul 01, 2022 / Published Date: Jul 30, 2022
Abstract
MicroRNAs (miRs) have recently emerged as important regulators of intracellular gene expression. In miR, which is often dysregulated in cancer, sheds new light on the molecular mechanisms of carcinogenesis and is of great interest as a biomarker and new therapies and targets. Recently, many studies have investigated the miR biology of Ewing sarcoma. The results indicate that changes in miR expression are widespread in Ewing sarcoma, including both carcinogenic EWS / Ets fusion-dependent and independent mechanisms, and contribute to a malignant phenotype.MiRs with potential prognosis have been identified, and several preclinical studies suggest that miR manipulation may be therapeutically useful for this invasive disease.
Citation: Boulytcheva I (2022) Usage of MicroRNA in Potential Therapeutics of Ewing’s Sarcoma. J Orthop Oncol 8: 173. Doi: 10.4172/2472-016X.1000173
Copyright: © 2022 Boulytcheva I. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1414
- [From(publication date): 0-2022 - Aug 17, 2024]
- Breakdown by view type
- HTML page views: 1232
- PDF downloads: 182